[Hypophosphatemic osteomalacia associated phosphaturic mesenchymal tumor of bone: report of a case].
Oncogenic osteomalacia caused by phosphaturic mesenchymal tumor of the temporal bone.
Progressive bone pain caused by a phosphaturic mesenchymal tumor in the left femur: a case report and literature review.
Phosphaturic Mesenchymal Tumor.
Benson JC, Trejo-Lopez JA, Nassiri AM, Eschbacher K, Link MJ, Driscoll CL, Tiegs RD, Sfeir J, DeLone DR.
AJNR Am J Neuroradiol. 2022 Jun;43(6):817-822. doi: 10.3174/ajnr.A7513. Epub 2022 May 19.
Tumor-induced Osteomalacia: A Comprehensive Review.
Minisola S, Fukumoto S, Xia W, Corsi A, Colangelo L, Scillitani A, Pepe J, Cipriani C, Thakker RV.
Endocr Rev. 2023 Mar 4;44(2):323-353. doi: 10.1210/endrev/bnac026.
Unexpected Phosphaturic Mesenchymal Tumor of the Femoral Head.
Wang H, Li W, Zhang W, Wang P, Wang S, Zhang R.
Diagnostics (Basel). 2023 May 5;13(9):1632. doi: 10.3390/diagnostics13091632.
Burosumab for the Treatment of Tumor-Induced Osteomalacia.
Jan de Beur SM, Miller PD, Weber TJ, Peacock M, Insogna K, Kumar R, Rauch F, Luca D, Cimms T, Roberts MS, San Martin J, Carpenter TO.
J Bone Miner Res. 2021 Apr;36(4):627-635. doi: 10.1002/jbmr.4233. Epub 2021 Jan 12.
Imaging characteristics of phosphaturic mesenchymal tumors.
Gupta A, Kandasamy D, Sharma R, Damle N, Goyal A, Goyal A, Agarwal S, Dharmashaktu Y.
Acta Radiol. 2023 Jun;64(6):2061-2073. doi: 10.1177/02841851231160086. Epub 2023 Mar 13.
Clinical Characteristics of Malignant Phosphaturic Mesenchymal Tumor Causing Tumor-Induced Osteomalacia.
Abate V, Vergatti A, De Filippo G, Damiano V, Menale C, D'Elia L, Rendina D.
J Clin Endocrinol Metab. 2024 Feb 20;109(3):e1006-e1011. doi: 10.1210/clinem/dgad690.
Tumor-Induced Osteomalacia.
Florenzano P, Hartley IR, Jimenez M, Roszko K, Gafni RI, Collins MT.
Calcif Tissue Int. 2021 Jan;108(1):128-142. doi: 10.1007/s00223-020-00691-6. Epub 2020 Jun 5.
Delayed diagnosis of occult phosphaturic mesenchymal tumor in the foot.
Correia J, Machado M, Gonçalves R, Jonge F, Micaelo M, Pedrosa C, Portela J.
Radiol Case Rep. 2021 Apr 9;16(6):1355-1362. doi: 10.1016/j.radcr.2021.03.015. eCollection 2021 Jun.
[Clinical and immunohistopathologic study of phosphaturic mesenchymal tumor].
Li DM, Wu HW, Li JD, Xia WB, Jiang Y, Zhong DR.
Zhonghua Bing Li Xue Za Zhi. 2018 Jun 8;47(6):427-431. doi: 10.3760/cma.j.issn.0529-5807.2018.06.008.
Phosphaturic mesenchymal tumor: Clinicopathological features with outcomes in 10 patients with review of literature.
Parameshwar VC, Rekhi B, Duggad A, Ramadwar M.
Indian J Pathol Microbiol. 2024 Apr 1;67(2):306-311. doi: 10.4103/ijpm.ijpm_295_23. Epub 2023 Nov 9.
